BMS-650032, an NS3 inhibitor, in combination with peginterferon alpha-2a and ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis C infection

Authors
Category Primary study
JournalJournal of Hepatology
Year 2011
This article has no abstract
Epistemonikos ID: 572dfeaddae93b024e6408ae4151ad5f7d3eedb7
First added on: Feb 04, 2025